ARCHIVE

• Diovan Remains No.1 for 6th Month in a Row: Rep Track Survey
  December 3, 2007

• Kyowa Hakko and Kirin Pharma Are a Perfect Match: Dr Matsuda
  December 3, 2007

• Wider Range of Drugs to Be Re-Priced in Next Price Revision
  December 3, 2007

• Re-Pricing of ARBs May Be Necessary: Mr Niwa
  December 3, 2007

• Council Calls For "Extraordinary NHI Drug Price Cuts"
  December 3, 2007

• Re-Pricing Runs Counter to the Promotion of Innovation: Dr Aoki
  December 3, 2007

• REGULATORY NEWS IN BRIEF
  December 3, 2007

• Delay in Start of PI between Japan and West Reduced to 4-6 Months: AstraZeneca
  December 3, 2007

• Suzuken: Two-Digit Growth in Sales, Profits
  November 26, 2007

• Ono to Minimize Impact of Generics by Further Expanding the Market
  November 26, 2007

• Aiming at Launching at Least One Product per Year: Genzyme
  November 26, 2007

• Toho Pharm.: Operating Profits Down 1.1% Due to Cost of Distribution Center
  November 26, 2007

• TOPICS／Eli Lilly Japan Introduces Mentor System for Female MRs
  November 26, 2007

• AnGes MG Licenses NF-kB Decoy Oligo to Meyer Pharm.
  November 26, 2007

• Santen: Good Sales in Europe Drive Business
  November 26, 2007

• BUSINESS NEWS IN BRIEF
  November 26, 2007

• Kaken to File NDA for KCB-1D for Regeneration of Periodontal Tissue in FY2009
  November 26, 2007

• Sales, Profit Growth Rates Slow Down for Major Generic Firms
  November 26, 2007

• Kyorin: Operating Profits Up 43% on the Strength of New Drugs
  November 26, 2007

• Sawai: Increases in Sales Slow Down, Sharp Drop in Profits
  November 26, 2007

ページ

• « 先頭
• ‹ Prev
• …
• 303
• 304
• 305
• 306
• 307
• 308
• 309
• 310
• 311
• …
• Next ›
• 最終 »